v3.25.1
Condensed Statements of Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Sales $ 341,264 $ 271,140
Cost of sales (excluding depreciation expense) 117,266 88,532
Operating expenses:    
Research and development 2,968,472 1,770,731
Sales and marketing 908,567 300,487
General and administrative 1,722,713 1,502,804
Depreciation and amortization 84,853 71,228
Total operating expenses 5,684,605 3,645,250
Loss from operations (5,460,607) (3,462,642)
Other (expense) income:    
Interest income 19,029 224,684
Interest expense (459,449) (361,552)
Total other (expense) income, net (440,420) (136,868)
Loss before income taxes (5,901,027) (3,599,510)
Income tax (benefit) (4,188) 0
Net loss (5,896,839) (3,599,510)
Net loss attributable to common stockholders, basic (5,896,839) (3,599,510)
Net loss attributable to common stockholders, diluted $ (5,896,839) $ (3,599,510)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.23) $ (0.17)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.23) $ (0.17)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares) 25,149,236 21,775,357
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) 25,149,236 21,775,357